Melanoma/Skin Cancer

Top Story

Patients may be receptive to skin cancer screening via artificial intelligence

March 25, 2020
In the Journals

Sharp declines in melanoma mortality 'unprecedented in cancer medicine'

March 19, 2020
The introduction and approval of new treatments for metastatic melanoma has led to significant declines in population-level mortality over the past several years…

SGX301 induces response in cutaneous T-cell lymphoma

March 19, 2020
A phase 3 trial designed to evaluate SGX301 for treatment of cutaneous T-cell lymphoma met its primary endpoint, according to the agent’s manufacturer. The FLASH…
In the Journals

Anti-PD-1 therapy induces durable long-term responses in advanced melanoma

March 19, 2020
About three-quarters of patients with advanced melanoma who achieved complete responses to single-agent anti-PD-1 therapy remained in remission at 3 years, according to…
More Headlines »
CME

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

This activity is supported by educational grants from Bristol-Myers Squibb; Iovance Biotherapeutics; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.

More »
Video
Meeting News

VIDEO: Cemiplimab demonstrates ‘impressive activity’ for metastatic cutaneous squamous cell carcinoma

June 19, 2018
More »
CME

Ace the Case: A 44-Year-Old Man With a History of Melanoma and a New Onset of Brain Metastases

There is no commercial support for this activity.

More »